John Young
Fortune : 3 M $ au 31/05/2026
Fortune : 3 M $ au 31/05/2026
John D.
Young is Director at Johnson Controls, Inc., Independent Non-Executive Director at Novartis AG since 2023, Independent Director at Johnson Controls International Plc since 2017, Member of the Ministerial Industry Strategy Group since 2008, and Member of the Life Sciences Council.
Former roles include Chairman & Managing Director at Pfizer Ltd., Independent Director at Arvinas, Inc. from 2022 to 2025, Director at Biotechnology Innovation Organization from 2018 to 2021, Director at European Federation of Pharmaceutical Industries & Assns from 2012 to 2017, Director at Imbria Pharmaceuticals, Inc. from 2022 to 2024, Non-Executive Director at Haleon Plc from 2022 to 2023, Chief Business Officer at Pfizer Inc. from 2019 to 2021, President at Hospira, Inc., Group President at Pfizer Essential Health from 2016 to 2018, and Member of the National Committee on United States-China Relations, Inc. from 2014 to 2017.
Education includes undergraduate studies at the University of Glasgow and an MBA from Strathclyde Business School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/03/2026 | 17 157 ( 0 % ) | 2 M $ | 31/05/2026 | |
NOVARTIS AG 0 % | 31/12/2025 | 3 649 ( 0 % ) | 550 234 $ | 31/05/2026 |
ARVINAS, INC. 0,04 % | 25/06/2025 | 26 045 ( 0,04 % ) | 233 884 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| JOHNSON CONTROLS INTERNATIONAL PLC | Directeur/Membre du Conseil | 01/12/2017 |
| JOHNSON CONTROLS INC | Directeur/Membre du Conseil | - |
| NOVARTIS AG | Directeur/Membre du Conseil | 07/03/2023 |
Life Sciences Council | Corporate Officer/Principal | - |
Ministerial Industry Strategy Group | Corporate Officer/Principal | 01/01/2008 |
| Sociétés | Poste | Fin |
|---|---|---|
| ARVINAS, INC. | Directeur/Membre du Conseil | 30/06/2025 |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Directeur/Membre du Conseil | 01/07/2024 |
| HALEON PLC | Directeur/Membre du Conseil | 28/02/2023 |
| PFIZER INC. | Corporate Officer/Principal | 01/12/2021 |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 17 |
|---|---|
Johnson Controls, Inc.
Johnson Controls, Inc. Packaged SoftwareTechnology Services Provides building technology and software & automation system solutions | Technology Services |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Health Technology |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
National Committee on United States-China Relations, Inc.
National Committee on United States-China Relations, Inc. The non-profit company is based in New York, NY. It connects senior officials, experts, and citizens from both countries through public education, dialogues, and exchange programs, focusing on issues such as international relations, economic development, governance, legal affairs, environment, media, education, military and security, and societal and cultural exchanges. The committee organizes track II dialogues on topics including the digital economy, climate finance, healthcare, human rights, maritime issues, and strategic security, and runs leadership development initiatives for emerging professionals. It partners with programs like Schwarzman Scholars to prepare future leaders in U.S.-China relations and conducts public education efforts through nationwide programs, multimedia series, and resources addressing Sino-American relations, anti-Asian racism, and bilateral economic and security challenges. The National Committee on United States-China Relations, Inc. is a private, nonpartisan nonprofit organization founded in 1966 to promote mutual understanding and cooperation between the peoples of the United States and China. | |
Strathclyde Business School
Strathclyde Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arvinas, Inc.
Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Ministerial Industry Strategy Group | |
Johnson Controls International Plc
Johnson Controls International Plc Industrial MachineryProducer Manufacturing Provides building products, energy solutions, integrated infrastructure and next generation transportation systems | Producer Manufacturing |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Commercial Services |
Life Sciences Council | |
Haleon Plc
Haleon Plc Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures oral, pain relief, digestive and respiratory health products, vitamins & supplements | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national